FREDERIKKE JEPPESEN KRAGH – QUANTITATIVE MEASUREMENTS OF MOTOR SIGNS IN DEMENTIA
Her study investigates whether a quantitative motor assessment provides a more objective, sensitive and standardised measurement of motor dysfunction in AD, FTD and DLB. A second area of interest is different aspects of physical activity and its impact on daily living functions in AD.
RACHEL UNDERLIEN KRISTENSEN – REGISTER-BASED RESEARCH ON POLYPHARMACY IN DEMENTIA
Using nationwide data, her project investigates the frequency and time trends of polypharmacy among people with and without dementia to examine potential disparities.
CHRISTINA STRAND-HOLM MANNICHE – CSF BIOMARKERS IN NPH, VASCULAR DEMENTIA AND AD
Her project investigates the ability of specific biomarkers in CSF to distinguish idiopathic N from subcortical ischemic vascular dementia and AD.
CHUQIAO CHEN – DISEASE MODELING OF FRONTOTEMPORAL DEMENTIA LINKED TO CHROMOSOME 3
Her project investigates relevant molecular mechanisms of distinct Danish and German FTD-3 mutations, using various cell models, including 1) patientderived fibroblast, 2) induced pluripotent stem cells, derived from patient fibroblasts, 3) a neuroblastoma knock-out model, overexpressing the different FTD-3 mutations.
JOHANNE KØBSTRUP ZAKARIAS – EPIDEMIOLOGY AND QUALITY OF DEMENTIA DIAGNOSES
Using nationwide registry data, this project investigated potential geographical variation in diagnostic rate and quality of dementia diagnoses to examine possible inequality in the access to appropriate diagnostic evaluation and care for patients with dementia.